Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
3 clinical trials · Condition
◉ Watch Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
| Record | Firm | Date |
|---|---|---|
| A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab (NCT07003100) | City of Hope Medical Center | 2024-12-06 |
| Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma (NCT04930653) | City of Hope Medical Center | 2022-10-19 |
| Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides (NCT03695471) | Mayo Clinic | 2020-02-04 |
Track Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.